Compare STRO & KRAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STRO | KRAQ |
|---|---|---|
| Founded | 2003 | 2025 |
| Country | United States | United States |
| Employees | 133 | 2 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.8M | 427.8M |
| IPO Year | N/A | N/A |
| Metric | STRO | KRAQ |
|---|---|---|
| Price | $26.85 | $9.97 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $31.33 | N/A |
| AVG Volume (30 Days) | ★ 303.0K | 70.2K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $9.78 |
| 52 Week High | $43.85 | $9.99 |
| Indicator | STRO | KRAQ |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 67.22 |
| Support Level | $23.53 | $9.87 |
| Resistance Level | $27.96 | N/A |
| Average True Range (ATR) | 2.87 | 0.02 |
| MACD | -0.33 | 0.00 |
| Stochastic Oscillator | 40.44 | 92.86 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Krakacquisition Corp is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.